🔎 Trials Near Me

Hjem › Ewing-sarkom › New York

Ewing-sarkom kliniske forsøg i New York

12 studier for Ewing-sarkom søger deltagere på steder i New York.

Byer i New York

Officiel studietekst (engelsk)

Evaluation of Xaluritamig in Adults, Adolescents and Children With Relapsed or Refractory Ewing Sarcoma (EWS)

  • Memorial Sloan Kettering Cancer Center, New York
RekruttererFase 1
Alder 2 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT07297979

Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes

  • Roswell Park Comprehensive Cancer Center, Buffalo
  • Montefiore Medical Center, The Bronx
RekruttererFase 1
Alder 1 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT07194044

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

  • Memorial Sloan Kettering Cancer Center ( Site 1010), New York
  • New York Medical College ( Site 1023), Valhalla
RekruttererFase 1/2
6 Months – 25 Years · Alle køn · Opdateret 17. sep. 2026 · NCT06395103

Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas

  • David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
RekruttererFase 1
Alder 12 til 85 · Alle køn · Opdateret 8. sep. 2026 · NCT03715933

Lurbinectedin in FET-Fused Tumors

  • Memorial Sloan Kettering Cancer Center, New York
RekruttererFase 1/2
Alder 10 og opefter · Alle køn · Opdateret 2. sep. 2026 · NCT05918640

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
RekruttererFase 1/2
12 Months – 30 Years · Alle køn · Opdateret 25. aug. 2026 · NCT04851119

A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies

  • Memorial Sloan Kettering Cancer Center, New York
RekruttererFase 1
Alder 16 og opefter · Alle køn · Opdateret 2. jun. 2026 · NCT07197554

Assessment of Healing and Function After Reconstruction Surgery for Bone Sarcomas

  • Memorial Sloan Kettering Westchester (Consent and Followup), Harrison
  • Memorial Sloan Kettering Cancer Center, New York
  • Memorial Sloan Kettering at Nassau (Consent and Followup), Uniondale
RekruttererObservationsstudie
Alder 4 og opefter · Alle køn · Opdateret 17. apr. 2026 · NCT03442465

Vorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS Malignancies

  • New York Medical College, Valhalla
RekruttererFase 1
Alder 1 til 30 · Alle køn · Opdateret 15. apr. 2026 · NCT04308330

Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

  • Albert Einstein College of Medicine, Children's Hospital at Montefiore, The Bronx
  • New York Medical Center/ Maria Fareri Children's Hospital, Valhalla
RekruttererFase 2
Alder 1 til 50 · Alle køn · Opdateret 13. mar. 2026 · NCT01804634

Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma

  • Memorial Sloan Kettering Cancer Center, New York
RekruttererFase 1/2
Alder 2 til 30 · Alle køn · Opdateret 3. feb. 2026 · NCT05734066

A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors

  • Children's Hospital at Montefiore, The Bronx
RekruttererFase 2
18 Months – 40 Years · Alle køn · Opdateret 12. aug. 2025 · NCT05135975

Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.